A*Star's Genome Institute Of Singapore, Nanostring, Next Level Genomics Established A Joint Laboratory In Singapore Focusing On Applying Spatial Biology To Identify Biomarkers To Predict Disease Progression And Treatment Response
Portfolio Pulse from Benzinga Newsdesk
A*Star's Genome Institute of Singapore, NanoString Technologies (NSTG), and Next Level Genomics have established a joint laboratory in Singapore, named SpACE-Dx lab. The lab will focus on applying spatial biology to identify biomarkers to predict disease progression and treatment response, primarily in cancer research.
October 03, 2023 | 10:05 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
NanoString Technologies is part of a new joint lab in Singapore focusing on spatial biology for disease prediction and treatment response. This could potentially enhance NSTG's research capabilities and product offerings.
The establishment of the new lab could potentially enhance NanoString's research capabilities and product offerings in the field of spatial biology, which could lead to the development of new products and services. This could potentially increase the company's revenues and profitability in the future, positively impacting its stock price.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100